List of Ceva Sante Animale patents

Patents where

Current Assignee

Name

Ceva Sante Animale

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11559491 Oral compositions and the preparation methods thereof	Patent 11559491 was granted and assigned to Ceva Sante Animale on January, 2023 by the United States Patent and Trademark Office.	Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	11559491	January 24, 2023
‌ US Patent 10174084 Fusion polypeptides and vaccines	Patent 10174084 was granted and assigned to Ceva Sante Animale on January, 2019 by the United States Patent and Trademark Office.	Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	10174084	January 8, 2019
‌ US Patent 11331321 Triazine formulations with a second active ingredient and surfactant(s)	Patent 11331321 was granted and assigned to Ceva Sante Animale on May, 2022 by the United States Patent and Trademark Office.	Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	11331321	May 17, 2022
‌ US Patent 11331296 Pheromone compositions and uses thereof	Patent 11331296 was granted and assigned to Ceva Sante Animale on May, 2022 by the United States Patent and Trademark Office.	Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	11331296	May 17, 2022
‌ US Patent 11318156 Solid injectable veterinary implants comprising monocyclic lactone	Patent 11318156 was granted and assigned to Ceva Sante Animale on May, 2022 by the United States Patent and Trademark Office.	Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	11318156	May 3, 2022
‌ US Patent 11529418 Temperature-controlled semiochemical composition diffusers		Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	11529418	December 20, 2022
‌ US Patent 10202582 Duck enteritis virus and the uses thereof	Patent 10202582 was granted and assigned to Ceva Sante Animale on February, 2019 by the United States Patent and Trademark Office.	Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	10202582	February 12, 2019
‌ US Patent 11116741 Method for the treatment of valvular heart disease comprising administering a composition comprising sarpogrelate	Patent 11116741 was granted and assigned to Ceva Sante Animale on September, 2021 by the United States Patent and Trademark Office.	Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	11116741	September 14, 2021
‌ US Patent 8703468 Porcine circovirus type 2B isolate and uses thereof	Patent 8703468 was granted and assigned to Ceva Sante Animale on April, 2014 by the United States Patent and Trademark Office.		Ceva Sante Animale	United States Patent and Trademark Office	8703468	April 22, 2014
‌ US Patent 9877969 Treatments with triazines	Patent 9877969 was granted and assigned to Ceva Sante Animale on January, 2018 by the United States Patent and Trademark Office.	Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	9877969	January 30, 2018
‌ US Patent 8999395 Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions	Patent 8999395 was granted and assigned to Ceva Sante Animale on April, 2015 by the United States Patent and Trademark Office.		Ceva Sante Animale	United States Patent and Trademark Office	8999395	April 7, 2015
‌ US Patent 11123425 Multivalent recombinant avian herpes viruses and vaccines for immunizing avian species	Patent 11123425 was granted and assigned to Ceva Sante Animale on September, 2021 by the United States Patent and Trademark Office.	Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	11123425	September 21, 2021
‌ US Patent 9744158 Veterinary antiprolactinic composition for ruminants	Patent 9744158 was granted and assigned to Ceva Sante Animale on August, 2017 by the United States Patent and Trademark Office.	Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	9744158	August 29, 2017
‌ US Patent 7915239 Process for treating lameness administration of a bisphosphonic acid derivative	Patent 7915239 was granted and assigned to Ceva Sante Animale on March, 2011 by the United States Patent and Trademark Office.		Ceva Sante Animale	United States Patent and Trademark Office	7915239	March 29, 2011
‌ US Patent 8933126 Methods of administering a mixture of fatty acids for the treatment of non-human mammals	Patent 8933126 was granted and assigned to Ceva Sante Animale on January, 2015 by the United States Patent and Trademark Office.		Ceva Sante Animale	United States Patent and Trademark Office	8933126	January 13, 2015
‌ US Patent 9687544 Veterinary vaccine	Patent 9687544 was granted and assigned to Ceva Sante Animale on June, 2017 by the United States Patent and Trademark Office.		Ceva Sante Animale	United States Patent and Trademark Office	9687544	June 27, 2017
‌ US Patent 9550812 Synthetic capsid proteins and uses thereof	Patent 9550812 was granted and assigned to Ceva Sante Animale on January, 2017 by the United States Patent and Trademark Office.		Ceva Sante Animale	United States Patent and Trademark Office	9550812	January 24, 2017
‌ US Patent 11439599 Scored tablet		Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	11439599	September 13, 2022
‌ US Patent 9730923 Antiprolactinic veterinary composition for ruminants	Patent 9730923 was granted and assigned to Ceva Sante Animale on August, 2017 by the United States Patent and Trademark Office.		Ceva Sante Animale	United States Patent and Trademark Office	9730923	August 15, 2017
‌ US Patent 11020472 Multivalent recombinant SPV	Patent 11020472 was granted and assigned to Ceva Sante Animale on June, 2021 by the United States Patent and Trademark Office.	Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	11020472	June 1, 2021
‌ US Patent D752730 Liquid dispenser	Patent D752730 was granted and assigned to Ceva Sante Animale on March, 2016 by the United States Patent and Trademark Office.	Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	D752730	March 29, 2016
‌ US Patent 10704028 Duck enteritis virus and the uses thereof		Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	10704028	July 7, 2020
‌ US Patent 10717967 Duck enteritis virus and the uses thereof		Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	10717967	July 21, 2020
‌ US Patent 10711255 Duck enteritis virus and the uses thereof		Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	10711255	July 14, 2020
‌ US Patent 10106819 Recombinant swinepox virus and vaccines	Patent 10106819 was granted and assigned to Ceva Sante Animale on October, 2018 by the United States Patent and Trademark Office.	Ceva Sante Animale	Ceva Sante Animale	United States Patent and Trademark Office	10106819	October 23, 2018

Results per page:

46 results

0 selected

46 results

0 selected